Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Dare Bioscience, Inc. - Common Stock (NQ: DARE ) 3.300 +0.100 (+3.12%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Dare Bioscience, Inc. - Common Stock < Previous 1 2 3 4 Next > Earnings Scheduled For November 14, 2024 November 14, 2024 Via Benzinga Insights into Dare Bioscience's Upcoming Earnings November 13, 2024 Via Benzinga DARE Stock Earnings: Dare Bioscience Beats Revenue for Q2 2024 August 12, 2024 DARE stock results show that Dare Bioscience beat on revenue for the second quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Intraday Session May 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session May 21, 2024 Via Benzinga Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval May 17, 2024 Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo. Via Benzinga Recap: Dare Bioscience Q4 Earnings March 28, 2024 Via Benzinga Dare Bioscience Earnings Preview March 27, 2024 Via Benzinga Earnings Outlook For Dare Bioscience November 08, 2023 Via Benzinga Earnings Outlook For Dare Bioscience August 09, 2023 Via Benzinga Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 21, 2024 Via Benzinga DARE Stock Earnings: Dare Bioscience Misses EPS, Beats Revenue for Q1 2024 May 14, 2024 DARE stock results show that Dare Bioscience missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Intraday Session April 30, 2024 Via Benzinga Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session April 25, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session April 24, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session April 17, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session March 28, 2024 Via Benzinga DARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023 March 28, 2024 DARE stock results show that Dare Bioscience beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. Via InvestorPlace First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks February 21, 2024 Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions. Via Benzinga Earnings Scheduled For March 28, 2024 March 28, 2024 Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday February 01, 2024 It's time to get into the biggest pre-market stock movers as we check out all of the hottest news happening on Thursday morning! Via InvestorPlace Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful Menstruation December 20, 2023 Daré Bioscience Inc (NASDAQ: DARE) announced topline results from the Phase 1 DARE-PDM1-001 study evaluating the pharmacokinetics (PK), safety, and exploratory efficacy of DARE-PDM1 an investigational... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 20, 2023 Via Benzinga FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding December 07, 2023 Daré Bioscience Inc (NASDAQ: DARE) announced that the FDA has cleared its investigational new drug (IND) application for DARE-VVA1 as a non-hormonal treatment option for moderate to severe dyspareunia,... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 07, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session October 16, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session September 20, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Monday July 31, 2023 On Monday, 27 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday July 21, 2023 On Friday, 54 companies hit new 52-week lows. Via Benzinga < Previous 1 2 3 4 Next > Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
